 | • レポートコード：GIR-107A12132 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、がん支持療法用薬品のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。がん支持療法用薬品の種類別市場規模（顆粒球コロニー刺激因子（G-CSFS）、エリスロポエチン刺激剤（ESAS）、制吐剤、ビスフォスフォネート、オピオイド、非ステロイド性抗炎症薬（NSAIDS）、その他）、用途別市場規模（乳がん、肺がん、黒色腫、前立腺がん、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・がん支持療法用薬品の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Amgen、Johnson & Johnson、Novartis、Baxter International、Fagron Group、Teva Pharmaceuticals Industries、F.Hoffmann La-Roche Ltd、Apr Applied Pharma Science Research、Acacia Pharma、Kyowa Hakko Kirin、Helsinn Healthcare、Heron Pharma、Merck & Co. Inc、Sanofi ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：顆粒球コロニー刺激因子（G-CSFS）、エリスロポエチン刺激剤（ESAS）、制吐剤、ビスフォスフォネート、オピオイド、非ステロイド性抗炎症薬（NSAIDS）、その他 ・用途別分析2016年-2026年：乳がん、肺がん、黒色腫、前立腺がん、その他 ・がん支持療法用薬品の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・がん支持療法用薬品のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・がん支持療法用薬品のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・がん支持療法用薬品の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・がん支持療法用薬品の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Cancer Supportive Care Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Cancer Supportive Care Drugs size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Cancer Supportive Care Drugs market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Cancer Supportive Care Drugs market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Granulocyte-Colony Stimulating Factors (G-CSFS)
Erythropoietin-Stimulating Agents (ESAS)
Antiemetics
Bisphosphonates
Opioids
Nonsteroidal Anti-Inflammatory Drugs (NSAIDS)
Others
Market segment by Application, can be divided into
Breast Cancer
Lung Cancer
Melanoma
Prostate Cancer
Others
Market segment by players, this report covers
Amgen
Johnson & Johnson
Novartis
Baxter International
Fagron Group
Teva Pharmaceuticals Industries
F.Hoffmann La-Roche Ltd
Apr Applied Pharma Science Research
Acacia Pharma
Kyowa Hakko Kirin
Helsinn Healthcare
Heron Pharma
Merck & Co. Inc
Sanofi
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Cancer Supportive Care Drugs
1.2 Classification of Cancer Supportive Care Drugs by Type
1.2.1 Overview: Global Cancer Supportive Care Drugs Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Cancer Supportive Care Drugs Revenue Market Share by Type in 2020
1.2.3 Granulocyte-Colony Stimulating Factors (G-CSFS)
1.2.4 Erythropoietin-Stimulating Agents (ESAS)
1.2.5 Antiemetics
1.2.6 Bisphosphonates
1.2.7 Opioids
1.2.8 Nonsteroidal Anti-Inflammatory Drugs (NSAIDS)
1.2.9 Others
1.3 Global Cancer Supportive Care Drugs Market by Application
1.3.1 Overview: Global Cancer Supportive Care Drugs Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Breast Cancer
1.3.3 Lung Cancer
1.3.4 Melanoma
1.3.5 Prostate Cancer
1.3.6 Others
1.4 Global Cancer Supportive Care Drugs Market Size & Forecast
1.5 Global Cancer Supportive Care Drugs Market Size and Forecast by Region
1.5.1 Global Cancer Supportive Care Drugs Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Cancer Supportive Care Drugs Market Size by Region, (2016-2021)
1.5.3 North America Cancer Supportive Care Drugs Market Size and Prospect (2016-2026)
1.5.4 Europe Cancer Supportive Care Drugs Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Cancer Supportive Care Drugs Market Size and Prospect (2016-2026)
1.5.6 South America Cancer Supportive Care Drugs Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Cancer Supportive Care Drugs Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Cancer Supportive Care Drugs Market Drivers
1.6.2 Cancer Supportive Care Drugs Market Restraints
1.6.3 Cancer Supportive Care Drugs Trends Analysis
2 Company Profiles
2.1 Amgen
2.1.1 Amgen Details
2.1.2 Amgen Major Business
2.1.3 Amgen Cancer Supportive Care Drugs Product and Solutions
2.1.4 Amgen Cancer Supportive Care Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Amgen Recent Developments and Future Plans
2.2 Johnson & Johnson
2.2.1 Johnson & Johnson Details
2.2.2 Johnson & Johnson Major Business
2.2.3 Johnson & Johnson Cancer Supportive Care Drugs Product and Solutions
2.2.4 Johnson & Johnson Cancer Supportive Care Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Johnson & Johnson Recent Developments and Future Plans
2.3 Novartis
2.3.1 Novartis Details
2.3.2 Novartis Major Business
2.3.3 Novartis Cancer Supportive Care Drugs Product and Solutions
2.3.4 Novartis Cancer Supportive Care Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Novartis Recent Developments and Future Plans
2.4 Baxter International
2.4.1 Baxter International Details
2.4.2 Baxter International Major Business
2.4.3 Baxter International Cancer Supportive Care Drugs Product and Solutions
2.4.4 Baxter International Cancer Supportive Care Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Baxter International Recent Developments and Future Plans
2.5 Fagron Group
2.5.1 Fagron Group Details
2.5.2 Fagron Group Major Business
2.5.3 Fagron Group Cancer Supportive Care Drugs Product and Solutions
2.5.4 Fagron Group Cancer Supportive Care Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Fagron Group Recent Developments and Future Plans
2.6 Teva Pharmaceuticals Industries
2.6.1 Teva Pharmaceuticals Industries Details
2.6.2 Teva Pharmaceuticals Industries Major Business
2.6.3 Teva Pharmaceuticals Industries Cancer Supportive Care Drugs Product and Solutions
2.6.4 Teva Pharmaceuticals Industries Cancer Supportive Care Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Teva Pharmaceuticals Industries Recent Developments and Future Plans
2.7 F.Hoffmann La-Roche Ltd
2.7.1 F.Hoffmann La-Roche Ltd Details
2.7.2 F.Hoffmann La-Roche Ltd Major Business
2.7.3 F.Hoffmann La-Roche Ltd Cancer Supportive Care Drugs Product and Solutions
2.7.4 F.Hoffmann La-Roche Ltd Cancer Supportive Care Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 F.Hoffmann La-Roche Ltd Recent Developments and Future Plans
2.8 Apr Applied Pharma Science Research
2.8.1 Apr Applied Pharma Science Research Details
2.8.2 Apr Applied Pharma Science Research Major Business
2.8.3 Apr Applied Pharma Science Research Cancer Supportive Care Drugs Product and Solutions
2.8.4 Apr Applied Pharma Science Research Cancer Supportive Care Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Apr Applied Pharma Science Research Recent Developments and Future Plans
2.9 Acacia Pharma
2.9.1 Acacia Pharma Details
2.9.2 Acacia Pharma Major Business
2.9.3 Acacia Pharma Cancer Supportive Care Drugs Product and Solutions
2.9.4 Acacia Pharma Cancer Supportive Care Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Acacia Pharma Recent Developments and Future Plans
2.10 Kyowa Hakko Kirin
2.10.1 Kyowa Hakko Kirin Details
2.10.2 Kyowa Hakko Kirin Major Business
2.10.3 Kyowa Hakko Kirin Cancer Supportive Care Drugs Product and Solutions
2.10.4 Kyowa Hakko Kirin Cancer Supportive Care Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Kyowa Hakko Kirin Recent Developments and Future Plans
2.11 Helsinn Healthcare
2.11.1 Helsinn Healthcare Details
2.11.2 Helsinn Healthcare Major Business
2.11.3 Helsinn Healthcare Cancer Supportive Care Drugs Product and Solutions
2.11.4 Helsinn Healthcare Cancer Supportive Care Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Helsinn Healthcare Recent Developments and Future Plans
2.12 Heron Pharma
2.12.1 Heron Pharma Details
2.12.2 Heron Pharma Major Business
2.12.3 Heron Pharma Cancer Supportive Care Drugs Product and Solutions
2.12.4 Heron Pharma Cancer Supportive Care Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Heron Pharma Recent Developments and Future Plans
2.13 Merck & Co. Inc
2.13.1 Merck & Co. Inc Details
2.13.2 Merck & Co. Inc Major Business
2.13.3 Merck & Co. Inc Cancer Supportive Care Drugs Product and Solutions
2.13.4 Merck & Co. Inc Cancer Supportive Care Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 Merck & Co. Inc Recent Developments and Future Plans
2.14 Sanofi
2.14.1 Sanofi Details
2.14.2 Sanofi Major Business
2.14.3 Sanofi Cancer Supportive Care Drugs Product and Solutions
2.14.4 Sanofi Cancer Supportive Care Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.14.5 Sanofi Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Cancer Supportive Care Drugs Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Cancer Supportive Care Drugs Players Market Share
3.2.2 Top 10 Cancer Supportive Care Drugs Players Market Share
3.2.3 Market Competition Trend
3.3 Cancer Supportive Care Drugs Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Cancer Supportive Care Drugs Revenue and Market Share by Type (2016-2021)
4.2 Global Cancer Supportive Care Drugs Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Cancer Supportive Care Drugs Revenue Market Share by Application (2016-2021)
5.2 Cancer Supportive Care Drugs Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Cancer Supportive Care Drugs Revenue by Type (2016-2026)
6.2 North America Cancer Supportive Care Drugs Revenue by Application (2016-2026)
6.3 North America Cancer Supportive Care Drugs Market Size by Country
6.3.1 North America Cancer Supportive Care Drugs Revenue by Country (2016-2026)
6.3.2 United States Cancer Supportive Care Drugs Market Size and Forecast (2016-2026)
6.3.3 Canada Cancer Supportive Care Drugs Market Size and Forecast (2016-2026)
6.3.4 Mexico Cancer Supportive Care Drugs Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Cancer Supportive Care Drugs Revenue by Type (2016-2026)
7.2 Europe Cancer Supportive Care Drugs Revenue by Application (2016-2026)
7.3 Europe Cancer Supportive Care Drugs Market Size by Country
7.3.1 Europe Cancer Supportive Care Drugs Revenue by Country (2016-2026)
7.3.2 Germany Cancer Supportive Care Drugs Market Size and Forecast (2016-2026)
7.3.3 France Cancer Supportive Care Drugs Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Cancer Supportive Care Drugs Market Size and Forecast (2016-2026)
7.3.5 Russia Cancer Supportive Care Drugs Market Size and Forecast (2016-2026)
7.3.6 Italy Cancer Supportive Care Drugs Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Cancer Supportive Care Drugs Revenue by Type (2016-2026)
8.2 Asia-Pacific Cancer Supportive Care Drugs Revenue by Application (2016-2026)
8.3 Asia-Pacific Cancer Supportive Care Drugs Market Size by Region
8.3.1 Asia-Pacific Cancer Supportive Care Drugs Revenue by Region (2016-2026)
8.3.2 China Cancer Supportive Care Drugs Market Size and Forecast (2016-2026)
8.3.3 Japan Cancer Supportive Care Drugs Market Size and Forecast (2016-2026)
8.3.4 South Korea Cancer Supportive Care Drugs Market Size and Forecast (2016-2026)
8.3.5 India Cancer Supportive Care Drugs Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Cancer Supportive Care Drugs Market Size and Forecast (2016-2026)
8.3.7 Australia Cancer Supportive Care Drugs Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Cancer Supportive Care Drugs Revenue by Type (2016-2026)
9.2 South America Cancer Supportive Care Drugs Revenue by Application (2016-2026)
9.3 South America Cancer Supportive Care Drugs Market Size by Country
9.3.1 South America Cancer Supportive Care Drugs Revenue by Country (2016-2026)
9.3.2 Brazil Cancer Supportive Care Drugs Market Size and Forecast (2016-2026)
9.3.3 Argentina Cancer Supportive Care Drugs Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Cancer Supportive Care Drugs Revenue by Type (2016-2026)
10.2 Middle East & Africa Cancer Supportive Care Drugs Revenue by Application (2016-2026)
10.3 Middle East & Africa Cancer Supportive Care Drugs Market Size by Country
10.3.1 Middle East & Africa Cancer Supportive Care Drugs Revenue by Country (2016-2026)
10.3.2 Turkey Cancer Supportive Care Drugs Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Cancer Supportive Care Drugs Market Size and Forecast (2016-2026)
10.3.4 UAE Cancer Supportive Care Drugs Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Cancer Supportive Care Drugs Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Cancer Supportive Care Drugs Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Cancer Supportive Care Drugs Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Cancer Supportive Care Drugs Revenue (USD Million) by Region (2016-2021)
Table 5. Global Cancer Supportive Care Drugs Revenue Market Share by Region (2021-2026)
Table 6. Amgen Corporate Information, Head Office, and Major Competitors
Table 7. Amgen Major Business
Table 8. Amgen Cancer Supportive Care Drugs Product and Solutions
Table 9. Amgen Cancer Supportive Care Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Johnson & Johnson Corporate Information, Head Office, and Major Competitors
Table 11. Johnson & Johnson Major Business
Table 12. Johnson & Johnson Cancer Supportive Care Drugs Product and Solutions
Table 13. Johnson & Johnson Cancer Supportive Care Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Novartis Corporate Information, Head Office, and Major Competitors
Table 15. Novartis Major Business
Table 16. Novartis Cancer Supportive Care Drugs Product and Solutions
Table 17. Novartis Cancer Supportive Care Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Baxter International Corporate Information, Head Office, and Major Competitors
Table 19. Baxter International Major Business
Table 20. Baxter International Cancer Supportive Care Drugs Product and Solutions
Table 21. Baxter International Cancer Supportive Care Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Fagron Group Corporate Information, Head Office, and Major Competitors
Table 23. Fagron Group Major Business
Table 24. Fagron Group Cancer Supportive Care Drugs Product and Solutions
Table 25. Fagron Group Cancer Supportive Care Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Teva Pharmaceuticals Industries Corporate Information, Head Office, and Major Competitors
Table 27. Teva Pharmaceuticals Industries Major Business
Table 28. Teva Pharmaceuticals Industries Cancer Supportive Care Drugs Product and Solutions
Table 29. Teva Pharmaceuticals Industries Cancer Supportive Care Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. F.Hoffmann La-Roche Ltd Corporate Information, Head Office, and Major Competitors
Table 31. F.Hoffmann La-Roche Ltd Major Business
Table 32. F.Hoffmann La-Roche Ltd Cancer Supportive Care Drugs Product and Solutions
Table 33. F.Hoffmann La-Roche Ltd Cancer Supportive Care Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Apr Applied Pharma Science Research Corporate Information, Head Office, and Major Competitors
Table 35. Apr Applied Pharma Science Research Major Business
Table 36. Apr Applied Pharma Science Research Cancer Supportive Care Drugs Product and Solutions
Table 37. Apr Applied Pharma Science Research Cancer Supportive Care Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Acacia Pharma Corporate Information, Head Office, and Major Competitors
Table 39. Acacia Pharma Major Business
Table 40. Acacia Pharma Cancer Supportive Care Drugs Product and Solutions
Table 41. Acacia Pharma Cancer Supportive Care Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Kyowa Hakko Kirin Corporate Information, Head Office, and Major Competitors
Table 43. Kyowa Hakko Kirin Major Business
Table 44. Kyowa Hakko Kirin Cancer Supportive Care Drugs Product and Solutions
Table 45. Kyowa Hakko Kirin Cancer Supportive Care Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Helsinn Healthcare Corporate Information, Head Office, and Major Competitors
Table 47. Helsinn Healthcare Major Business
Table 48. Helsinn Healthcare Cancer Supportive Care Drugs Product and Solutions
Table 49. Helsinn Healthcare Cancer Supportive Care Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Heron Pharma Corporate Information, Head Office, and Major Competitors
Table 51. Heron Pharma Major Business
Table 52. Heron Pharma Cancer Supportive Care Drugs Product and Solutions
Table 53. Heron Pharma Cancer Supportive Care Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Merck & Co. Inc Corporate Information, Head Office, and Major Competitors
Table 55. Merck & Co. Inc Major Business
Table 56. Merck & Co. Inc Cancer Supportive Care Drugs Product and Solutions
Table 57. Merck & Co. Inc Cancer Supportive Care Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. Sanofi Corporate Information, Head Office, and Major Competitors
Table 59. Sanofi Major Business
Table 60. Sanofi Cancer Supportive Care Drugs Product and Solutions
Table 61. Sanofi Cancer Supportive Care Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 62. Global Cancer Supportive Care Drugs Revenue (USD Million) by Players (2019-2021)
Table 63. Global Cancer Supportive Care Drugs Revenue Share by Players (2019-2021)
Table 64. Breakdown of Cancer Supportive Care Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 65. Cancer Supportive Care Drugs Players Head Office, Products and Services Provided
Table 66. Cancer Supportive Care Drugs Mergers & Acquisitions in the Past Five Years
Table 67. Cancer Supportive Care Drugs New Entrants and Expansion Plans
Table 68. Global Cancer Supportive Care Drugs Revenue (USD Million) by Type (2016-2021)
Table 69. Global Cancer Supportive Care Drugs Revenue Share by Type (2016-2021)
Table 70. Global Cancer Supportive Care Drugs Revenue Forecast by Type (2021-2026)
Table 71. Global Cancer Supportive Care Drugs Revenue by Application (2016-2021)
Table 72. Global Cancer Supportive Care Drugs Revenue Forecast by Application (2021-2026)
Table 73. North America Cancer Supportive Care Drugs Revenue by Type (2016-2021) & (USD Million)
Table 74. North America Cancer Supportive Care Drugs Revenue by Type (2021-2026) & (USD Million)
Table 75. North America Cancer Supportive Care Drugs Revenue by Application (2016-2021) & (USD Million)
Table 76. North America Cancer Supportive Care Drugs Revenue by Application (2021-2026) & (USD Million)
Table 77. North America Cancer Supportive Care Drugs Revenue by Country (2016-2021) & (USD Million)
Table 78. North America Cancer Supportive Care Drugs Revenue by Country (2021-2026) & (USD Million)
Table 79. Europe Cancer Supportive Care Drugs Revenue by Type (2016-2021) & (USD Million)
Table 80. Europe Cancer Supportive Care Drugs Revenue by Type (2021-2026) & (USD Million)
Table 81. Europe Cancer Supportive Care Drugs Revenue by Application (2016-2021) & (USD Million)
Table 82. Europe Cancer Supportive Care Drugs Revenue by Application (2021-2026) & (USD Million)
Table 83. Europe Cancer Supportive Care Drugs Revenue by Country (2016-2021) & (USD Million)
Table 84. Europe Cancer Supportive Care Drugs Revenue by Country (2021-2026) & (USD Million)
Table 85. Asia-Pacific Cancer Supportive Care Drugs Revenue by Type (2016-2021) & (USD Million)
Table 86. Asia-Pacific Cancer Supportive Care Drugs Revenue by Type (2021-2026) & (USD Million)
Table 87. Asia-Pacific Cancer Supportive Care Drugs Revenue by Application (2016-2021) & (USD Million)
Table 88. Asia-Pacific Cancer Supportive Care Drugs Revenue by Application (2021-2026) & (USD Million)
Table 89. Asia-Pacific Cancer Supportive Care Drugs Revenue by Region (2016-2021) & (USD Million)
Table 90. Asia-Pacific Cancer Supportive Care Drugs Revenue by Region (2021-2026) & (USD Million)
Table 91. South America Cancer Supportive Care Drugs Revenue by Type (2016-2021) & (USD Million)
Table 92. South America Cancer Supportive Care Drugs Revenue by Type (2021-2026) & (USD Million)
Table 93. South America Cancer Supportive Care Drugs Revenue by Application (2016-2021) & (USD Million)
Table 94. South America Cancer Supportive Care Drugs Revenue by Application (2021-2026) & (USD Million)
Table 95. South America Cancer Supportive Care Drugs Revenue by Country (2016-2021) & (USD Million)
Table 96. South America Cancer Supportive Care Drugs Revenue by Country (2021-2026) & (USD Million)
Table 97. Middle East & Africa Cancer Supportive Care Drugs Revenue by Type (2016-2021) & (USD Million)
Table 98. Middle East & Africa Cancer Supportive Care Drugs Revenue by Type (2021-2026) & (USD Million)
Table 99. Middle East & Africa Cancer Supportive Care Drugs Revenue by Application (2016-2021) & (USD Million)
Table 100. Middle East & Africa Cancer Supportive Care Drugs Revenue by Application (2021-2026) & (USD Million)
Table 101. Middle East & Africa Cancer Supportive Care Drugs Revenue by Country (2016-2021) & (USD Million)
Table 102. Middle East & Africa Cancer Supportive Care Drugs Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Cancer Supportive Care Drugs Picture
Figure 2. Global Cancer Supportive Care Drugs Revenue Market Share by Type in 2020
Figure 3. Granulocyte-Colony Stimulating Factors (G-CSFS)
Figure 4. Erythropoietin-Stimulating Agents (ESAS)
Figure 5. Antiemetics
Figure 6. Bisphosphonates
Figure 7. Opioids
Figure 8. Nonsteroidal Anti-Inflammatory Drugs (NSAIDS)
Figure 9. Others
Figure 10. Cancer Supportive Care Drugs Revenue Market Share by Application in 2020
Figure 11. Breast Cancer Picture
Figure 12. Lung Cancer Picture
Figure 13. Melanoma Picture
Figure 14. Prostate Cancer Picture
Figure 15. Others Picture
Figure 16. Global Cancer Supportive Care Drugs Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 17. Global Cancer Supportive Care Drugs Revenue and Forecast (2016-2026) & (USD Million)
Figure 18. Global Cancer Supportive Care Drugs Revenue Market Share by Region (2016-2026)
Figure 19. Global Cancer Supportive Care Drugs Revenue Market Share by Region in 2020
Figure 20. North America Cancer Supportive Care Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 21. Europe Cancer Supportive Care Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 22. Asia-Pacific Cancer Supportive Care Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 23. South America Cancer Supportive Care Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 24. Middle East and Africa Cancer Supportive Care Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 25. Cancer Supportive Care Drugs Market Drivers
Figure 26. Cancer Supportive Care Drugs Market Restraints
Figure 27. Cancer Supportive Care Drugs Market Trends
Figure 28. Amgen Recent Developments and Future Plans
Figure 29. Johnson & Johnson Recent Developments and Future Plans
Figure 30. Novartis Recent Developments and Future Plans
Figure 31. Baxter International Recent Developments and Future Plans
Figure 32. Fagron Group Recent Developments and Future Plans
Figure 33. Teva Pharmaceuticals Industries Recent Developments and Future Plans
Figure 34. F.Hoffmann La-Roche Ltd Recent Developments and Future Plans
Figure 35. Apr Applied Pharma Science Research Recent Developments and Future Plans
Figure 36. Acacia Pharma Recent Developments and Future Plans
Figure 37. Kyowa Hakko Kirin Recent Developments and Future Plans
Figure 38. Helsinn Healthcare Recent Developments and Future Plans
Figure 39. Heron Pharma Recent Developments and Future Plans
Figure 40. Merck & Co. Inc Recent Developments and Future Plans
Figure 41. Sanofi Recent Developments and Future Plans
Figure 42. Global Cancer Supportive Care Drugs Revenue Share by Players in 2020
Figure 43. Cancer Supportive Care Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 44. Global Top 3 Players Cancer Supportive Care Drugs Revenue Market Share in 2020
Figure 45. Global Top 10 Players Cancer Supportive Care Drugs Revenue Market Share in 2020
Figure 46. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 47. Global Cancer Supportive Care Drugs Revenue Share by Type in 2020
Figure 48. Global Cancer Supportive Care Drugs Market Share Forecast by Type (2021-2026)
Figure 49. Global Cancer Supportive Care Drugs Revenue Share by Application in 2020
Figure 50. Global Cancer Supportive Care Drugs Market Share Forecast by Application (2021-2026)
Figure 51. North America Cancer Supportive Care Drugs Sales Market Share by Type (2016-2026)
Figure 52. North America Cancer Supportive Care Drugs Sales Market Share by Application (2016-2026)
Figure 53. North America Cancer Supportive Care Drugs Revenue Market Share by Country (2016-2026)
Figure 54. United States Cancer Supportive Care Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Canada Cancer Supportive Care Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Mexico Cancer Supportive Care Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Europe Cancer Supportive Care Drugs Sales Market Share by Type (2016-2026)
Figure 58. Europe Cancer Supportive Care Drugs Sales Market Share by Application (2016-2026)
Figure 59. Europe Cancer Supportive Care Drugs Revenue Market Share by Country (2016-2026)
Figure 60. Germany Cancer Supportive Care Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. France Cancer Supportive Care Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. United Kingdom Cancer Supportive Care Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Russia Cancer Supportive Care Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Italy Cancer Supportive Care Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Asia-Pacific Cancer Supportive Care Drugs Sales Market Share by Type (2016-2026)
Figure 66. Asia-Pacific Cancer Supportive Care Drugs Sales Market Share by Application (2016-2026)
Figure 67. Asia-Pacific Cancer Supportive Care Drugs Revenue Market Share by Region (2016-2026)
Figure 68. China Cancer Supportive Care Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Japan Cancer Supportive Care Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. South Korea Cancer Supportive Care Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. India Cancer Supportive Care Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Southeast Asia Cancer Supportive Care Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Australia Cancer Supportive Care Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. South America Cancer Supportive Care Drugs Sales Market Share by Type (2016-2026)
Figure 75. South America Cancer Supportive Care Drugs Sales Market Share by Application (2016-2026)
Figure 76. South America Cancer Supportive Care Drugs Revenue Market Share by Country (2016-2026)
Figure 77. Brazil Cancer Supportive Care Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Argentina Cancer Supportive Care Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Middle East and Africa Cancer Supportive Care Drugs Sales Market Share by Type (2016-2026)
Figure 80. Middle East and Africa Cancer Supportive Care Drugs Sales Market Share by Application (2016-2026)
Figure 81. Middle East and Africa Cancer Supportive Care Drugs Revenue Market Share by Country (2016-2026)
Figure 82. Turkey Cancer Supportive Care Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 83. Saudi Arabia Cancer Supportive Care Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 84. UAE Cancer Supportive Care Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 85. Methodology
Figure 86. Research Process and Data Source
世界のがん支持療法用製品市場 2021：企業別、地域別、種類・用途別 The Cancer Supportive Care Products market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade…- 世界の乳がん用HER-2標的薬市場 2021：企業別、地域別、種類・用途別 The HER-2 Targeted Drugs for Breast Cancer market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization…
- 世界の乳がん治療薬市場 2021：企業別、地域別、種類・用途別 The Breast Cancer Treatment Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade r…
- 世界の腎臓・腎臓がん治療薬市場 2021：企業別、地域別、種類・用途別 The Kidney & Renal Cancer Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade reg…
- 世界の卵巣がん治療薬市場 2021：企業別、地域別、種類・用途別 The Ovarian Cancer Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulation…